Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers

Isr Med Assoc J. 2014 May;16(5):315-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angioedema* / drug therapy
  • Angioedema* / etiology
  • Angioedema* / immunology
  • Angioedema* / physiopathology
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antiphospholipid Syndrome / complications*
  • Autoantibodies / blood
  • Complement C1 Inhibitor Protein / immunology*
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Lymphocyte Depletion / methods
  • Monitoring, Immunologic
  • Myasthenia Gravis / complications*
  • Remission Induction
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Complement C1 Inhibitor Protein
  • Immunologic Factors
  • Rituximab

Supplementary concepts

  • Acquired angioedema